Zimmer Biomet Holdings ZBH US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zimmer Biomet Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zimmer Biomet Holdings's us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zimmer Biomet Holdings's US — revenue?
- Zimmer Biomet Holdings (ZBH) reported US — revenue of $1.21B in Q1 2026.
- How has Zimmer Biomet Holdings's US — revenue changed year-over-year?
- Zimmer Biomet Holdings's US — revenue increased by 8.6% year-over-year, from $1.11B to $1.21B.
- What is the long-term trend for Zimmer Biomet Holdings's US — revenue?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's US — revenue has grown at a 5.4% compound annual growth rate (CAGR), from $3.85B to $4.76B.
- What does US — revenue mean?
- This metric represents the total gross revenue generated from the sale of orthopedic products and surgical services within the United States geographic segment, net of any assessed taxes. It reflects the core commercial performance of the company's largest market, capturing the volume and pricing power of reconstructive implants and related surgical equipment. This figure serves as a primary indicator of market penetration and demand for the company's portfolio in the domestic healthcare sector.